A double-blind randomized study comparing the efficacy and safety of a composite vs a conventional intravenous fat emulsion in postsurgical gastrointestinal tumor patients

Nutrition in Clinical Practice

Volumn 27, Issue 3, 2012, Pages 410-415

  Ma, Cheng Jen ^a,b   Sun, Li Chu ^b   Chen, Fang Ming ^a,b,c   Lu, Chien Yu ^b,c   Shih, Ying Ling ^b   Tsai, Hsiang Lin ^b,d   Chuang, Jui Fen ^b   Wang, Jaw Yuan ^a,b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d FOOYIN UNIVERSITY   (Taiwan)

Author keywords

fat emulsions, intravenous; fatty acids, omega 3; gastrointestinal neoplasms; parenteral nutrition

Indexed keywords

FISH OIL; LIPID EMULSION; LONG CHAIN TRIACYLGLYCEROL; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL TUMOR; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NAUSEA AND VOMITING; OLIVE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; TREATMENT OUTCOME;

AGED; COLONIC NEOPLASMS; DOUBLE-BLIND METHOD; FAT EMULSIONS, INTRAVENOUS; FISH OILS; GASTROINTESTINAL NEOPLASMS; HUMANS; MIDDLE AGED; PARENTERAL NUTRITION; PLANT OILS; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; SOYBEAN OIL; STOMACH NEOPLASMS; TRIGLYCERIDES;

GLYCINE MAX;

EID: 84861816739     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533611436115     Document Type: Article

References (34)

1. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 1993 ; 88: 523-533
2. Appel LJ, Miller ER, Seidler AJ, Whelton PK. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 1993 ; 153: 1429-1438
3. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis: clinical and immunologic effects. Arthritis Rheum. 1990 ; 33: 810-820
4. Guallar E, Aro A, Jimenez FJ, et al. Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: the EURAMIC study. Arterioscler Thromb Vasc Biol. 1999 ; 19: 1111-1118
5. von Schacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999 ; 130: 554-562
6. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002 ; 287: 1815-1821
7. Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol. 2000 ; 27: 2343-2346
8. Cleland LG, French JK, Betts WH, et al. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol. 1988 ; 15: 1471-1475
9. Lau CS, Morley KD, Belch JJ. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis-a double-blind placebo controlled study. Br J Rheumatol. 1993 ; 32: 982-989
10. Clark WF, Parbtani A, Naylor CD, et al. Fish oil in lupus nephritis: clinical findings and methodological implications. Kidney Int. 1993 ; 44: 75-86
11. Walton AJ, Snaith ML, Locniskar M, et al. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis. 1991 ; 50: 463-466
12. Meister D, Ghosh S. Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease. World J Gastroenterol. 2005 ; 11: 7466-7472
13. Hillier K, Jewell R, Dorrell L, Smith CL. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut. 1991 ; 32: 1151-1155
14. Lorenz R, Weber PC, Szimnau P, et al. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease-a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl. 1989 ; 731: 225-232
15. Grimm H, Kraus A. Immunonutrition-supplementary amino acids and fatty acids ameliorate immune deficiency in critically ill patients. Langenbecks Arch Surg. 2001 ; 386: 369-376
16. Carpentier YA, Simoens C, Siderova V, et al. Recent developments in fat emulsions: relevance to intensive care. Nutrition. 1997 ; 13: 73S - 78S
17. Koller M, Senkal M, Kemen M, et al. Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clin Nutr. 2003 ; 22: 59-64
18. Simopoulos AP, Leaf A, Salem N. Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab. 1999 ; 43: 127-130
19. Grimm H, Tibell A, Norrlind B, et al. Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio. JPEN J Parenter Enteral Nutr. 1994 ; 18: 417-421
20. Kinsella JE, Broughton KS, Whelan JW. Dietary unsaturated fatty acids: interactions and possible needs in relation to eicosanoid synthesis. J Nutr Biochem. 1990 ; 1: 123-141
21. Patino JF, de Pimiento SE, Vergara A, et al. Hypocaloric support in the critically ill. World J Surg. 1999 ; 23: 553-559
22. Wolfe BM, Ahuja SP. Effects of intravenously administered fructose and glucose on splanchnic secretion of plasma triglycerides in hypertriglyceridemic men. Metabolism. 1977 ; 26: 963-978
23. Harris WS, Ginsberg HN, Arunakul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk. 1997 ; 4: 385-391
24. Connor WE, DeFrancesco CA, Connor SL. N-3 fatty acids from fish oil: effects on plasma lipoproteins and hypertriglyceridemic patients. Ann N Y Acad Sci. 1993 ; 683: 16-34
25. Illingworth DR, Schmidt EB. The influence of dietary n-3 fatty acids on plasma lipids and lipoproteins. Ann N Y Acad Sci. 1993 ; 676: 60-69
26. Weintraub MS, Zechner R, Brown A, et al. Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels: chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest. 1988 ; 82: 1884-1893
27. Worne HE, Smith LW. Effects of certain pure long chain polyunsaturated fatty acid esters on the blood lipids of man; preliminary studies on the use of polyunsaturated fatty acid in atherosclerosis. Am J Med Sci. 1959 ; 237: 710-721
28. Parks JS, Rudel LL. Effect of fish oil on atherosclerosis and lipoprotein metabolism. Atherosclerosis. 1990 ; 84: 83-94
29. Vasandani C, Kafrouni AI, Caronna A, et al. Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. J Lipid Res. 2002 ; 43: 772-784
30. Wang H, Chen X, Fisher EA. N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes. J Clin Invest. 1993 ; 91: 1380-1389
31. Grimm H, Mertes N, Goeters C, et al. Improved fatty acid and leukotriene pattern with a novel fat emulsion in surgical patients. Eur J Nutr. 2006 ; 45: 55-60
32. Wachtler P, Konig W, Senkal M, et al. Influence of a total parenteral nutrition enriched with omega-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma. 1997 ; 42: 191-198
33. Morlion BJ, Torwesten E, Lessire H, et al. The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene-synthesizing capacity in patients with postoperative trauma. Metabolism. 1996 ; 45: 1208-1213
34. Vega-Lopez S, Kaul N, Devaraj S, et al. Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism. 2004 ; 53: 236-240